オプションチェーンは、Easterly Government Propsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Easterly Government Propsの市場センチメントを評価します。.

Easterly Government Props (NYSE:DEA) 株価情報, オプションチェーン

Easterly Government Props

Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.

Easterly Government Properties, Inc. Common Stock

Easterly Government Properties Inc

DEAPcoin

DEALERADVANCE INC NEW by DealerAdvance, Inc.

DealerAdvance Inc

DEAR CASHMERE HOLDING CO by Dear Cashmere Holding Co.

Dear Cashmere Holding Co

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Easterly Government Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</h3>
<ul>
<li>Easterly Government Properties will release its first quarter financial results on April 29. The company's stock fell around 23% over the past month and has a 52-week low of $7.79.</li>
<li>RSI Value: 23.8</li>
<li>DEA Price Action: Shares of Easterly Government Properties fell 0.8% to close at $8.30 on Tuesday.</li>
<li>Edge Stock Ratings: 18.64 Momentum score with Value at 59.92.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/DEA"><img loading="lazy" decoding="async" width="481" height="188" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061358/image-122.png" alt="" class="wp-image-873898" style="width:384px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061358/image-122.png 481w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061358/image-122-300x117.png 300w" sizes="(max-width: 481px) 100vw, 481px" /></a></figure>
<h3 class="wp-block-heading">Summit Hotel Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INN#NYSE">INN</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>Summit Hotel Properties will report financial results for the first quarter on Wednesday, April 30, after the market closes. The company's stock fell around 32% over the past month and<a href="https://www.benzinga.com/quote/INN"> has a 52-week low</a> of $3.57.</li>
<li>RSI Value: 24.6</li>
<li>INN Price Action: Shares of Summit Hotel Properties fell 1.8% to close at $3.94 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416">trend in INN stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416"><img loading="lazy" decoding="async" width="910" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123.png" alt="" class="wp-image-873900" style="width:590px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123-768x711.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">LXP Industrial Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXP#NYSE">LXP</a>)</h3>
<ul>
<li>LXP Industrial Trust  will release its first quarter financial results before the opening bell on Thursday, May 1. The company's stock fell around 16% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/LXP">low of $6.85</a>.</li>
<li>RSI Value: 28.4</li>
<li>LXP Price Action: Shares of LXP Industrial Trust gained 0.1% to close at $7.69 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416">LXP shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416"><img loading="lazy" decoding="async" width="877" height="430" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124.png" alt="" class="wp-image-873901" style="width:522px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124.png 877w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124-768x377.png 768w" sizes="(max-width: 877px) 100vw, 877px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44811698/jim-cramer-planet-fitness-is-doing-better-than-expected-says-no-to-this-industrial-stock">Jim Cramer: Planet Fitness Is Doing Better Than Expected, Says No To This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Top 3 Real Estate Stocks That May Explode In Q2

WIIM

APLE

Shares of REIT stocks are trading lower amid an overall market reversal. The sector may also be down amid a rise in the 30-year Treasury yield.

Dividends

CORRECTION: Easterly Government Properties Reduces Quarterly Dividend From $0.265 To $0.180

Guidance

Easterly Government Properties Says After Giving Effect To The Reverse Stock Split And The Payment Of The Company's Quarterly Cash Dividend, The Company Reaffirms Its 2025 Earnings Outlook

Stock Split

Easterly Government Properties Approved 1-For-25 Reverse Stock Split

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.
<h3 class="wp-block-heading">Easterly Government Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</h3>
<ul>
<li>Dividend Yield: 11.52%</li>
<li>RBC Capital analyst Michael Carroll maintained an Underperform rating and cut the price target from $12 to $11 on March 10, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Truist Securities analyst Michael Lewis maintained a Hold rating and slashed the price target from $14 to $13 on Dec. 6, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On March 25, Easterly Government Properties issued $125 million in senior unsecured notes.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">latest DEA news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="907" height="803" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47.png" alt="" class="wp-image-863275" style="width:479px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47-300x266.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47-768x680.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Park Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>)</h3>
<ul>
<li>Dividend Yield: 11.30%</li>
<li>Truist Securities analyst Patrick Scholes maintained a Buy rating and slashed the price target from $18 to $16 on March 21, 2025. This analyst has an accuracy rate of 62%.</li>
<li>UBS analyst Robin Farley maintained a Neutral rating and cut the price target from $15 to $13 on Feb. 3, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Recent News: Park Hotels &amp; Resorts will release its financial results for the first quarter before the stock market opens on Monday, May 5.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">latest PK news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="912" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48.png" alt="" class="wp-image-863276" style="width:516px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48-768x696.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">OUTFRONT Media Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUT#NYSE">OUT</a>)</h3>
<ul>
<li>Dividend Yield: 9.05%</li>
<li>Morgan Stanley analyst Benjamin Swinburne maintained an Equal-Weight rating and raised the price target from $17.51 to $18.54 on Dec. 18, 2024. This analyst has an accuracy rate of 76%.</li>
<li>TD Cowen analyst Lance Vitanza initiated coverage on the stock with a Hold rating and a price target of $16.48 on July 16, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On Feb. 25, Outfront Media reported fourth-quarter financial results and beat its EPS and revenue estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest OUT <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="915" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49.png" alt="" class="wp-image-863277" style="width:547px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49-300x268.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49-768x686.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 9% Dividend Yields

The U.S. <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration</a> (DEA) is trying to be cool again. And by "cool," we mean desperately attempting to curb the inevitable: weed is mainstream, legal in much of the U.S. and enjoying a global glow-up. But instead of rolling with the times, the DEA has teamed up with anti-cannabis nonprofit Johnny's Ambassadors to recruit young people for a TikTok—sorry, Instagram—campaign against <a href="https://www.benzinga.com/topic/thc">THC</a>. As <a href="https://www.marijuanamoment.net/dea-promotes-anti-420-day-contest-for-young-people-to-flood-instagram-with-marijuana-warnings/">reported</a> by Marijuana Moment&#8217;s Kyle Jaeger, the plan is to pay kids to make videos bashing weed because nothing says authenticity like a government-funded hashtag campaign.
<h3 class="wp-block-heading">Paying Teens To Say No To Weed</h3>
For its latest "Just Say No" remix, the DEA is <a href="https://content.govdelivery.com/accounts/USDOJDEAJTT/bulletins/3d86b96">dangling cash</a> in front of students to get them to post anti-THC videos ahead of April 20—aka 4/20, aka Christmas for stoners. The going rate? A whopping $25 for a solo rant, $35 for a group effort and a mighty $50 for a professionally shot skit (with adult supervision, of course). The goal? To "flood" Instagram with anti-cannabis content, telling young people that weed is bad.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/25/03/44476373/are-marijuana-taxes-too-high-they-already-beat-alcohol-and-tobacco-and-theyre-about-to-get-worse">Are Marijuana Taxes Too High? They Already Beat Alcohol And Tobacco And They&#8217;re About To Get Worse</a>
Johnny's Ambassadors, the group leading this crusade, wants videos explaining how THC supposedly tanks athletic performance, busting "myths" about cannabis, or sharing sob stories about how pot ruined someone's life. But let's be clear: no cussing, no laughing and absolutely no pretending to smoke not even as a joke.
<h3 class="wp-block-heading">The Timing Is…Suspicious</h3>
Now, let's talk about why this is weird. The DEA is in the middle of potentially rescheduling cannabis, a move that would mark the biggest federal shift on marijuana in decades. So why, in the middle of this seismic policy moment, is the agency pushing what feels like a D.A.R.E. campaign with better lighting?
Johnny's Ambassadors has a deeply personal backstory. The group was founded by parents of a teenager who died by suicide after consuming high-potency cannabis concentrates. Their grief is real, but their messaging leans hard into old-school fear tactics, avoiding the kind of harm reduction strategies that have proven effective elsewhere.
<h3 class="wp-block-heading">The DEA's Cringe-Worthy Track Record</h3>
This isn't even the DEA's first time fumbling the "relatable youth messaging" thing. In 2023, the agency suggested teens could get a "natural high" by becoming famous on Instagram or staring at puppies at a pet store. That really happened. And who could forget the infamous <a href="https://elplanteo.com/emojis-drogas-vender-dea/">guide on decoding "drug emojis,"</a> which had all the accuracy of a Boomer trying to interpret Gen Z slang?
Now, we've got the DEA awkwardly cosigning a campaign that's paying kids to be anti-weed influencers—while the rest of the country moves on, puffing away legally.
<h3 class="wp-block-heading">Can The DEA Stop The Inevitable?</h3>
The cannabis industry isn't slowing down. The DEA can fund as many Instagram campaigns as it wants, but the reality is clear: legal weed is a juggernaut, markets are expanding and public opinion is overwhelmingly pro-cannabis. The real question is, will this campaign actually get traction? Or will it be another entry in the DEA's Greatest Hits of Embarrassing Youth Outreach?
Either way, mark your calendars: April 20 is coming, and no Instagram video will stop the smoke from rolling in.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/03/44492783/420-in-san-francisco-heres-why-sf-space-walk-should-be-on-your-radar">4/20 In San Francisco? Here&#8217;s Why SF Space Walk Should Be On Your Radar</a></li>
</ul>
Lead image via Shutterstock

Cannabis

Government

Politics

The DEA Wants Teens To Become Anti-Weed Influencers For $25 A Pop

Jefferies analyst Peter Abramowitz initiates coverage on Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) with a Buy rating and announces Price Target of $13.

Initiation

Jefferies Initiates Coverage On Easterly Government Props with Buy Rating, Announces Price Target of $13

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.
<h3 class="wp-block-heading">Easterly Government Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</h3>
<ul>
<li>Dividend Yield: 10.33%</li>
<li>RBC Capital analyst Michael Carroll maintained an Underperform rating and cut the price target from $12 to $11 on March 10, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Truist Securities analyst Michael Lewis maintained a Hold rating and lowered the price target from $14 to $13 on Dec. 6, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On Feb. 25, Easterly Government Props posted fourth-quarter FFO of 29 cents, in-line with estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest DEA <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="905" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119.png" alt="" class="wp-image-824364" style="width:475px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119.png 905w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119-768x710.png 768w" sizes="(max-width: 905px) 100vw, 905px" /></a></figure>
<h3 class="wp-block-heading">Park Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>)</h3>
<ul>
<li>Dividend Yield: 9.17%</li>
<li>UBS analyst Robin Farley maintained a Neutral rating and cut the price target from $15 to $13 on Feb. 3, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Wolfe Research analyst Keegan Carl downgraded the stock from Outperform to Peer Perform on Sept. 26, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On Feb. 19, Park Hotels &amp; Resorts posted better-than-expected quarterly revenue.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">latest PK news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="900" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120.png" alt="" class="wp-image-824366" style="width:492px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120-768x714.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></a></figure>
<h3 class="wp-block-heading">Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>)</h3>
<ul>
<li>Dividend Yield: 7.60%</li>
<li>Wedbush analyst Richard Anderson downgraded the stock from Neutral to Underperform and cut the price target from $18 to $16 on Jan. 2, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Wells Fargo analyst James Feldman assumed an Underweight rating and raised the price target from $16 to $17 on Oct. 1, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Feb. 19, Healthcare Realty Trust reported quarterly earnings of 40 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">HR news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="845" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121.png" alt="" class="wp-image-824369" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121-768x712.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/03/44300558/jim-cramer-arthur-j-gallagher-is-solid-this-industrial-company-is-fantastic">Jim Cramer: Arthur J. Gallagher Is &#8216;Solid,&#8217; This Industrial Company Is &#8216;Fantastic&#8217;</a></li>
</ul>

Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields

RBC Capital analyst Michael Carroll maintains Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) with a Underperform and lowers the price target from $12 to $11.

RBC Capital Maintains Underperform on Easterly Government Props, Lowers Price Target to $11

Markets fell broadly Tuesday with the S&amp;P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a weaker-than-anticipated consumer confidence survey from the Conference Board, adding to concerns over the health of the U.S. <a href="https://www.benzinga.com/news/25/02/43949339/consumer-confidence-plummets-in-february-sharp-decline-marks-third-consecutive-monthly-drop">consumer and job market. </a>
Escalating trade concerns are also weighing on markets after President Donald Trump announced on Monday that tariffs on imports from Canada and Mexico "will go forward" and Bloomberg reported the White House is preparing tighter restrictions on semiconductor exports to China.&nbsp;
NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) led the Nasdaq lower as investors anticipate the company's earnings release on Wednesday and shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell after the EV giant saw a sharp decline in European sales. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst">Tesla Competes Against Chinese Rivals &#8216;With One Hand Tied Behind Its Back&#8217;: Analyst</a>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell below $88,000, its lowest since November 2024, as concerns over a slowing U.S. economy and Trump's trade policies<a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43945957/liquidity-is-disappearing-bitcoins-downturn-spells-doom-for-altcoins-analyst-warns"> weighed on </a>crypto markets. 
The yield on the U.S. 10-year Treasury note fell about 9 bps to 4.32% as investors flocked toward safe-haven assets.  The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) rose 1.49%. 
<h1 class="wp-block-heading">Tuesday's Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1 day % chg.</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,072.35</td>
<td>-1.12%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,957.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,597.47</td>
<td>0.31%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,165.29</td>
<td>-0.59%</td>
</tr>
</tbody>
</table>
</figure>
According to Benzinga Pro data:
<ul>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was down 0.48% to $594.36.</li>
<li>The SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) climbed 0.28% at $435.76.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) slid 0.98% to $514.78.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased down 0.38% to $215.41.</li>
<li>The Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) was down 0.8% to $215.84.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) fell 1.53% to $89.56.</li>
</ul>
<h1 class="wp-block-heading">Tuesday's Stock Movers </h1>
Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares plunged after<a href="https://www.benzinga.com/general/health-care/25/02/43926641/hims-hers-health-stock-drops-after-q4-report-eps-in-line-revenues-beat"> the company reported</a> a decline gross margins in the fourth-quarter added to concern over the end of the FDA-declared shortage of semaglutide.
Stocks reacting to company earnings reports included:&nbsp;
<ul>
<li>Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) </li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) </li>
<li>Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) </li>
<li>Easterly Government Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) </li>
<li>Keurig Dr Pepper Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) </li>
<li>Trip.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) </li>
</ul>
Companies reporting after Tuesday's closing bell include:&nbsp;
<ul>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) </li>
<li>AMC Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) </li>
<li>Workday, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) </li>
<li>Maplebear (Instacart) Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) </li>
<li>First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) </li>
<li>Caesars Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) </li>
<li>Coupang, Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) </li>
<li>Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) </li>
<li>CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) </li>
</ul>
Read Next:<a href="https://www.benzinga.com/news/earnings/25/02/43945252/lucid-q4-earnings-preview-production-deliveries-margins-on-watch"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43945252/lucid-q4-earnings-preview-production-deliveries-margins-on-watch">Lucid Q4 Earnings Preview: Production, Deliveries, Margins On Watch</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

Market Summary

Sector ETFs

Broad U.S. Equity ETFs

Treasuries

Movers

Tech

ETFs

General

$BTC

CART

CAVA

CHGG

CPNG

SPDR Dow Jones Industrial Average ETF Trust

DNUT

FSLR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

INTU

LCID

NVDA

TCOM

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

WDAY

Select Sector SPDR-Consumer Discretionary

Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday?

Easterly Government Props Sees 2025 Core FFO $1.18-$1.21 vs $1.20 Est.

Earnings

Earnings Misses

Easterly Government Props Q4 2024 FFO $0.29, Inline, Total Revenue $78.250M

AHCO

ALLT

ARQT

AXGN

AXON

BASE

BGFV

BLZE

BTDR

BWIN

CBLL

CCCS

CECO

CGBD

CHRD

CIFR

CPSS

DAWN

DOCN

DRVN

ELAN

EXLS

FIHL

FLYW

FULC

GPOR

HRMY

HSIC

HURN

HYLN

IART

ICCC

IGIC

IMOS

INGN

INVX

IPAR

ITRI

IVAC

JACK

JAZZ

KEYS

KNSA

LGIH

LIVN

LMND

LXFR

MASI

MATX

MFIC

MIDD

MMSI

MPLN

MRVI

NOVT

NXRT

Earnings Scheduled For February 25, 2025

President Donald Trump has tapped Terrance Cole, a former 22-year DEA official and Virginia public safety administrator, to take the helm of the <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration (DEA)</a>.
Trump announced the appointment Tuesday afternoon in a social media post. "Together, we will save lives, and MAKE AMERICA SAFE AGAIN," Trump <a href="https://x.com/TrumpDailyPosts/status/1889357392472842578">wrote</a> on Truth Social.
<h2 class="wp-block-heading">Bad News For Cannabis Rescheduling And Reform</h2>
Trump&#8217;s DEA choice dims hopes for a revival of the Biden administration-initiated <a href="https://www.benzinga.com/markets/cannabis/24/05/38880719/biden-announces-monumental-marijuana-rescheduling-doj-to-take-next-steps">marijuana rescheduling process</a>. 
Why exactly? Cole's stance on cannabis appears to align with the late former First Lady Nancy Reagan's 1980s-era "Just Say No" campaign that helped launch the deadly War on Drugs.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/07/33156524/dea-turns-50-unveiling-the-ineffectiveness-of-the-ongoing-war-on-drugs-now-what">$1 Trillion And 50 Years Later, Is The DEA&#8217;s War On Drugs A Failure?</a>
Despite Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40776937/trump-joins-millions-of-americans-who-support-rescheduling-cannabis-weed-industry-responds-to-fo">previously expressing support</a> during his campaign when he was up against VP Kamala Harris&#8217;s popular pro-cannabis stance, Cole's appointment provides no indication that the president will embrace cannabis reform anytime soon. 
<h2 class="wp-block-heading">Trump&#8217;s Real Stand? Actions Speak Louder Than Words</h2>
Less than a month in, Trump has already appointed tough-on-crime figures to key oversight roles, including Attorney General Pam Bondi, who <a href="https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform">opposed medical cannabis</a> in Florida and Office of Management and Budget (OMB) head <a href="https://www.benzinga.com/markets/24/11/42152862/trump-picks-project-2025-co-author-russell-vought-for-omb">Russ Vought</a>, who supported federal intervention in cannabis shops. Senate Majority Leader John Thune and House Speaker Mike Johnson, both from states without legal cannabis, are unlikely to advance pro-reform legislation.
Then there's the most important figure on the Trump team: Elon Musk, who recently <a href="https://www.benzinga.com/news/legal/25/02/43560520/elon-musk-who-smoked-weed-on-rogans-podcast-calls-federal-drug-testing-a-great-idea">praised drug testing</a> for federal workers, or what remains of them.
<h2 class="wp-block-heading">Cole's History With Virginia's Anti-Marijuana Governor</h2>
Cole, who spent more than two decades with the DEA before retiring in 2020, was the acting regional director overseeing operations across Canada, Central America and Mexico. He also worked as a special agent and criminal investigator in Oklahoma, Colombia and Afghanistan earlier &nbsp;in his career.
Following his DEA tenure, Cole joined Virginia Gov. Glenn Youngkin's administration as the state secretary of public safety and homeland security.
Youngkin, who has consistently <a href="https://www.benzinga.com/markets/cannabis/24/03/38002728/gop-governor-youngkin-vetoes-virginia-cannabis-sales-bill-3-years-after-legalization-sparking-de">opposed adult-use marijuana sales</a> in Virginia, praised Cole's appointment.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43643471/trump-administration-secures-release-of-cannabis-prisoner-marc-fogel-from-14-year-russian-sentence">Trump Administration Secures Release Of Cannabis Prisoner Marc Fogel From 14-Year Russian Sentence</a></li>
</ul>
Photo courtesy of @DEAHQ

Trump Appoints Anti-Cannabis 'Just Say No' Drug Warrior As DEA Chief To 'Make America Safe Again'

The Trump administration launched an immigration enforcement blitz in Chicago on Sunday, Immigration and Customs Enforcement (ICE) confirmed in a statement.
ICE agents are expected to be joined by officials from several more agencies in the multi-day operation that will soon spread across the country, seemingly beginning with Democratic-run states and cities.
The Chicago operation is part of a broader effort to beef up ICE in terms of resources and agents, as the Trump administration launches its nationwide crackdown toward fulfilling <a href="https://www.benzinga.com/news/25/01/43216758/well-go-as-far-as-im-allowed-trumps-plan-with-immigrants-starts-with-1-million-deportations">President Donald Trump&#8216;s vow</a> to deport one million people.  
"U.S. Immigration and Customs Enforcement, along with federal partners, including the FBI, ATF, DEA, CBP and the U.S. Marshals Service, began conducting enhanced targeted operations today in Chicago to enforce U.S. immigration law and preserve public safety and national security by keeping potentially dangerous criminal aliens out of our communities," the ICE <a href="https://www.ice.gov/news/releases/statement-us-immigration-and-customs-enforcement">statement</a> reads.
<h2 class="wp-block-heading">Dangerous Criminal Aliens? The Governor Begs To Differ</h2>
Illinois Gov. JB Pritzker (D) <a href="https://www.cnn.com/2025/01/26/politics/video/sotu-pritzker-on-planned-chicago-immigration-raids">told CNN's Dana Bash on Sunday</a> that he too wants violent criminals out of the country, but he expressed concern about how the Trump administration is carrying out operations.
"If that's who they're picking up, we're all for it." But, Prizker said, &#8220;they're going after people who are law-abiding, who are holding down jobs, who have families here, who may have been here for a decade or two decades. Why are we going after them? These are not people who are causing problems in our country.&#8221;
Read Also: <a href="https://www.benzinga.com/news/25/01/43216758/well-go-as-far-as-im-allowed-trumps-plan-with-immigrants-starts-with-1-million-deportations">&#8216;We&#8217;ll Go As Far As I&#8217;m Allowed&#8217;: Trump&#8217;s Plan With Immigrants Starts With 1 Million Deportations</a>
The Chicago Police Department said in a statement to <a href="https://www.cnn.com/2025/01/26/politics/chicago-immigration-trump-ice/index.html">CNN</a> it does not document immigration status, and in accordance with its "Welcoming City Ordinance," and that it "does not share information with federal immigration authorities." 
"We will not intervene or interfere with any other government agencies performing their duties," the Chicago PD statement reads.
Meanwhile, on Saturday U.S. Army troops patrolled Eagle Pass, Texas, reported CNN. following Trump's order to <a href="https://www.benzinga.com/markets/cannabis/25/01/43219037/texas-gov-abbott-wants-11-billion-border-security-reimbursement-protecting-the-rest-of-america-was-expensive">deploy 1,500 additional soldiers</a> to the U.S.-Mexico border, raising the total to 4,000. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/25/01/43137164/trumps-immigration-raids-will-disrupt-chicagos-economy-pritzker-says">Trump&#8217;s Immigration Raids Could Disrupt Key Sectors Of Chicago&#8217;s Economy: Pritzker Says To Focus On Criminals, Not Law-Abiding Workers</a></li>
</ul>
Photo courtesy of Chicago DEA

Trump's Immigration Enforcement Raids Begin In Chicago: Gov. Pritzker Concerned Innocents Could Be Targeted

Sen. <a href="https://www.benzinga.com/topic/elizabeth-warren">Elizabeth Warren</a> (D-Mass.) sent a detailed letter to <a href="https://www.benzinga.com/topic/elon-musk">Elon Musk</a>, chair of the newly established Department of Government Efficiency (DOGE) with <a href="https://www.benzinga.com/government/regulations/25/01/43182640/elizabeth-warren-lists-changes-for-elon-musks-doge-department-urges-guantanamo-closure-due-to-hundreds-of-millions-in-annual-costs">numerous suggestions</a> for slashing federal spending.
Warren outlined proposals she said could save the federal government upwards of $2 trillion over the next decade. Among her recommendations was scaling back federal enforcement against marijuana users and businesses, which she called an example of "wasteful spending."
"The United States could save hundreds of millions of dollars annually by cutting unnecessary federal enforcement actions and detention," Warren wrote in the <a href="https://www.warren.senate.gov/imo/media/doc/letter_to_doge_rerecommendationstosave2trillionoverthenext10years.pdf">Thursday letter</a> to the billionaire Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO. 
Warren criticized federal agencies like the <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration</a> (DEA) and Customs and Border Protection (CBP) for continuing to target legal marijuana businesses and seize cannabis plants. "These arrests and seizures unnecessarily drain federal resources," Warren said. 
When the DEA <a href="https://www.benzinga.com/markets/cannabis/23/07/33156524/dea-turns-50-unveiling-the-ineffectiveness-of-the-ongoing-war-on-drugs-now-what" target="_blank" rel="noreferrer noopener">celebrated its 50th anniversary&nbsp;</a>in 2023, it had spent over $1 trillion partly to enforce&nbsp;Richard Nixon&#8217;s&nbsp;1970 Controlled Substances Act, the cornerstone of his&nbsp;<a href="https://www.benzinga.com/topic/war-on-drugs" target="_blank" rel="noreferrer noopener">War on Drugs</a>.
Warren recommended to Musk that both the Departments of Justice and Homeland Security could also conserve resources by deprioritizing arrests and other actions targeting marijuana possession in jurisdictions where it's legal under state law. 
"For example, almost half of states have legalized recreational marijuana, yet federal arrests for marijuana possession account for roughly a quarter of all drug possession arrests, even though federal sentences for marijuana possession are rare," Warren wrote, referring to FBI data <a href="https://norml.org/blog/2024/09/25/fbi-nearly-one-quarter-of-all-drug-related-arrests-are-for-marijuana-possession/">made public</a> in September 2024.
The senator pointed to reports showing the DEA eradicated over 5.7 million marijuana plants in 2022 and criticized the agency for failing to release updated data on marijuana-related arrests and seizures in 2024. She also highlighted a lawsuit by licensed <a href="https://www.benzinga.com/markets/cannabis/24/10/41561733/lawsuit-against-the-feds-could-set-precedent-on-state-rights-new-mexico-marijuana-firms-move-to-">New Mexico cannabis businesses</a> accusing CBP agents of unconstitutional seizures and detentions.
Last week, <a href="https://www.benzinga.com/general/health-care/25/01/43107039/elizabeth-warren-questions-robert-f-kennedy-jr-on-dangerous-views-pot-legalization-timeline-as-his-senate-hearing-stalls">Warren expressed</a> "serious concerns" about Robert F. Kennedy Jr.'s ability to lead the Department of Health and Human Services. She asked for more information on Kennedy's &nbsp;stance regarding marijuana legalization and other issues including what she called his "dangerous views on vaccine safety and public health, including your baseless opposition to vaccines." 
On Wednesday, Kennedy will appear before the Senate Finance Committee for the first of two confirmation hearings
Meanwhile, the DEA's leadership has drawn scrutiny, with acting administrator Derek Maltz <a href="https://www.benzinga.com/news/global/25/01/43169554/trump-appoints-dea-chief-who-will-bring-ruthless-narco-terrorists-to-justice-not-keen-on-legalizing-cannabis">linking cannabis to issues like school shootings</a>, an unfounded and most agree ludicrous stance. 
In related news, on Saturday the Senate confirmed the nomination of former South Dakota governor&nbsp;<a href="https://www.benzinga.com/topic/kristi-noem">Kristi Noem&nbsp;</a>to lead the Dept. of Homeland Security. 
Now More:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/43169554/trump-appoints-dea-chief-who-will-bring-ruthless-narco-terrorists-to-justice-not-keen-on-legalizing-cannabis">Trump Appoints DEA Chief Who Will Bring &#8216;Ruthless Narco-Terrorists To Justice,&#8217; Not Keen On Legalizing Cannabis</a></li>
</ul>
Photo: Shutterstock

Legal

Elizabeth Warren To Elon Musk: Cut Unnecessary Federal Cannabis Enforcement And Save Billions

A new poll by NuggMD reveals a stark divide between frequent cannabis consumers and the Drug Enforcement Administration (DEA). According to the survey, conducted between January 16 and January 19, 2025, only 4% of respondents trust the DEA to be an &#8220;unbiased proponent&#8221; for cannabis rescheduling efforts. An overwhelming 96% said they do not.
The survey sampled 677 frequent cannabis users from a list of respondents who opted into NuggMD&#8217;s polls. With a margin of error of ±3.77%, the poll reflects widespread skepticism among a demographic directly affected by cannabis policy. The results came shortly after a federal hearing on cannabis rescheduling <a href="https://www.benzinga.com/25/01/42972524/dea-judge-cancels-marijuana-rescheduling-hearing-amid-disturbing-allegations-of-improper-conduct">was delayed for several months</a>, adding to the uncertainty surrounding the issue.
<h3 class="wp-block-heading">Consumer Trust In The DEA At Historic Lows</h3>
NuggMD, a company focused on medical cannabis evaluations and education, conducted the survey using first-party data from its consumer base. A spokesperson for the company emphasized the importance of this data in understanding public sentiment. &#8220;Cannabis consumers are the people most directly affected by federal cannabis prohibition, and the DEA has the power to enforce those laws,&#8221; said the company's head of communications.
"When an agency you oversee polls at 4% with one of your stakeholder groups, you either have a policy problem, a personnel problem, or both. The current administration needs to choose which problem it has before it can solve it," the statement continued.
This level of distrust highlights a significant challenge for policymakers attempting to navigate cannabis reform. The DEA's reputation as a prohibitionist agency has long been a sticking point for advocates and these survey results suggest the agency may face an uphill battle in regaining credibility with key stakeholders.
<h3 class="wp-block-heading">The Context: Delayed Rescheduling Hearing</h3>
The poll's timing is notable. It was conducted immediately after a federal hearing on rescheduling cannabis—a proposal that would shift the substance from Schedule I to Schedule III under the Controlled Substances Act—was put on hold. This delay has fueled frustrations within the cannabis community, where many see the DEA as a roadblock to meaningful reform.
Cannabis remains classified as a Schedule I substance, alongside drugs like heroin, under federal law. This classification indicates a high potential for abuse and no accepted medical use, despite growing evidence and state-level legalization efforts. Rescheduling cannabis to Schedule III would significantly ease restrictions, potentially allowing for greater research, federal tax deductions and other benefits.
<h3 class="wp-block-heading">Broader Implications</h3>
The findings of the NuggMD poll reveal deeper tensions in the cannabis debate. For decades, the DEA has been viewed as resistant to reform, a perception that persists even as public opinion has shifted dramatically in favor of legalization.
These results also present an opportunity for the Biden administration, which has shown openness to reform. Addressing the mistrust highlighted by this poll could help the administration make meaningful strides in cannabis policy while rebuilding trust with stakeholders.
For now, the message from cannabis consumers is clear: the DEA has significant work to do in proving it can act as a neutral party in rescheduling discussions. Whether through policy changes, personnel shifts, or increased transparency, any attempt to rebuild trust will require swift and decisive action.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/43169554/trump-appoints-dea-chief-who-will-bring-ruthless-narco-terrorists-to-justice-not-keen-on-legalizing-cannabis">Trump Appoints DEA Chief Who Will Bring &#8216;Ruthless Narco-Terrorists To Justice,&#8217; Not Keen On Legalizing Cannabis</a></li>
</ul>
Cover image made with AI

96% Of Cannabis Consumers Don't Trust DEA On Rescheduling Efforts: Poll

This week in cannabis was relatively subdued, with the most significant news stemming from Washington, D.C. The Trump administration appointed a controversial new acting DEA administrator, Derek S. Maltz, raising concerns over the future of cannabis rescheduling efforts. Meanwhile, updates from global markets in Germany, Uruguay and the Netherlands highlighted ongoing industry challenges and progress.
Here's a recap of this week's notable developments.
<h3 class="wp-block-heading">Politics</h3>
<h4 class="wp-block-heading">New DEA Leadership Sparks Cannabis Industry Concerns</h4>
The Trump administration <a href="https://www.benzinga.com/news/global/25/01/43169554/trump-appoints-dea-chief-who-will-bring-ruthless-narco-terrorists-to-justice-not-keen-on-legalizing-cannabis">appointed</a> Derek S. Maltz as the acting administrator of the U.S. Drug Enforcement Administration (DEA). A 28-year veteran of the agency, Maltz is known for his hardline stance on cannabis and drug policy. Maltz has criticized cannabis legalization, citing its alleged links to public safety concerns, and accused the Department of Justice of politicizing the cannabis rescheduling process.
"President Trump is off to a fast start as the 47th POTUS with border security and the horrible implications of cartels and drug trafficking in America as an area of major importance, so we are not surprised by the recent appointment of Derek Maltz as the Acting Administrator of the US DEA,&#8221; said Morgan Paxhia, co-founder and Managing Partner of <a href="https://mattio-dot-yamm-track.appspot.com/2pFzd1Qgmrif5VxFI2L_TFQmXMMHIhfA-E3vgz1Zem7pnchqPlAFxJWLFa7a_EcC7Kgp3W3RkyDRkUal94Mbleln_0lctmQ4C_TyNorrTe8gVXAycGFqk6OoFkP3yPy0_lG3I18yoHMnpIsHOSNSKxh8Vm_Nxe6qe0qi3fXcOUXZNoPVfc1jR" target="_blank" rel="noreferrer noopener">Poseidon</a>, a burgeoning cannabis investment fund. &#8220;President Trump has been getting smart on legal cannabis, sees the economic benefits and is pro MAGA and DOGE. We think it is better to focus less on any appointee's dated/biased views on cannabis and more so on POTUS as the primary input for potential legislative reform and as it pertains to the scheduling of cannabis."
This leadership change occurs amid significant delays in the DEA&#8217;s hearings on rescheduling cannabis from a Schedule I to a Schedule III substance under the Controlled Substances Act. Critics fear the Trump administration may abandon the process entirely, which could set back cannabis reform efforts.
Read more <a href="https://www.benzinga.com/news/global/25/01/43169554/trump-appoints-dea-chief-who-will-bring-ruthless-narco-terrorists-to-justice-not-keen-on-legalizing-cannabis">here</a>.
<h3 class="wp-block-heading">Markets</h3>
<h4 class="wp-block-heading">Ispire Technology Announces $10 Million Stock Buyback</h4>
In response to market volatility, Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) unveiled a $10 million stock buyback program to boost shareholder confidence. The company reaffirmed its commitment to long-term growth despite challenges in the broader cannabis market.
<h4 class="wp-block-heading">Earnings Reports On The Horizon</h4>
Cannabis giants are gearing up to report financial results, offering insights into the industry's trajectory:
<ul>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) will release Q3 2025 earnings on February 5, followed by a call at 8:00 a.m. ET.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) will publish its Q3 2025 results on February 7, with a webcast at 10:00 a.m. ET.</li>
<li>Green Thumb Industries (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>) will report Q4 and FY2024 results on February 26, accompanied by a call at 5:00 p.m. ET.</li>
</ul>
<h3 class="wp-block-heading">Global Updates</h3>
<h4 class="wp-block-heading">Uruguay's Cannabis Market Sees Record Sales</h4>
<a href="https://elplanteo.com/uruguay-2024-compradores-cannabis-legal/">Uruguay</a>'s regulated cannabis market hit new highs in 2024, with over 102,000 registered buyers and annual revenues of $30 million. The introduction of high-THC variants like <a href="https://elplanteo.com/uruguay-cannabis-thc-epsilon/">Épsilon</a> (20% THC) drove demand, with pharmacies selling 359 kilograms in just two months after its launch. The country continues to reduce illegal market activity, now capturing 50% of what was once unregulated sales.
<h4 class="wp-block-heading">Aurora Cannabis Launches First German-Cultivated Product</h4>
Aurora debuted its first German-cultivated medical cannabis product, IndiMed, marking a milestone for Europe's largest medical cannabis market. The launch highlights Aurora's commitment to premium, pharmaceutical-grade products, positioning the company as a leader in navigating complex European regulations.
<h4 class="wp-block-heading">Contaminated Cannabis Found In Dutch Coffee Shops</h4>
A study by the Trimbos Institute revealed alarming levels of contaminants in cannabis sold in Dutch coffee shops. Out of 50 samples tested, one-fifth showed microbiological contamination, and one-third contained pesticide residues. Notably, some samples had lead levels nearly six times the permissible limit under forthcoming regulations for a government-licensed trial.
The trial, set to launch in April, aims to improve quality control and curb illegal activity by introducing state-regulated cannabis supply chains. These findings underscore the urgent need for tighter oversight and regulations to ensure consumer safety in one of the world's oldest legal cannabis markets.
<h3 class="wp-block-heading">Celebrity Advocacy: Tyson and Angelos Applaud Trump's Reforms</h3>
Mike Tyson and Weldon Angelos <a href="https://www.benzinga.com/news/legal/25/01/43149460/trumps-cannabis-reform-mike-tyson-weldon-angelos-say-president-can-get-it-done">commended</a> President Trump for his commitment to cannabis reforms, including rescheduling efforts, banking access and clemency for non-violent cannabis offenders. Tyson called the cannabis industry a "multi-billion-dollar market" that fosters economic growth, while Angelos criticized the Biden administration's lackluster efforts on clemency for marijuana-related convictions.
<h3 class="wp-block-heading">Interesting Reads</h3>
To close up the week, below are some other interesting stories to check out:
<ul>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/01/20/how-european-cannabis-seed-companies-are-quietly-taking-over-the-us-market/">How European Cannabis Seed Companies Are Quietly Taking Over The U.S. Market</a></li>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/01/19/worlds-largest-tobacco-company-continues-silent-entry-into-cannabis-is-philip-morris-a-medical-marijuana-supporter/">World's Largest Tobacco Company Continues Silent Entry Into Cannabis: Is Philip Morris A Medical Marijuana Supporter?</a></li>
<li><a href="https://www.benzinga.com/news/global/25/01/43181165/raw-founder-celebrates-87m-legal-victory-in-a-very-peculiar-way-we-rolled-it-up-and-smoked-the-lawsuit-literally">RAW Founder Celebrates $8.7M Legal Victory In A Very Peculiar Way: &#8216;We Rolled It Up And Smoked The Lawsuit, Literally&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/25/01/43165973/the-dea-ruling-was-a-game-changer-why-this-european-cannabis-giant-is-betting-on-the-american-seeds-market">&#8216;The DEA Ruling Was A Game-Changer&#8217;: Why This European Cannabis Giant Is Betting On The American Seeds Market</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/25/01/42033610/whoopi-goldberg-talks-cannabis-the-planets-greatest-medicine-pain-reliever-and-source-of-joy">Whoopi Goldberg Talks Cannabis: The Planet&#8217;s &#8216;Greatest Medicine&#8230; Pain Reliever And Source Of Joy&#8217;</a></li>
<li><a href="https://www.benzinga.com/general/health-care/25/01/43111246/legal-marijuana-linked-to-drop-in-anxiety-medications-what-it-means-for-pharma-giants">Legal Marijuana Linked To Drop In Anxiety Medications: What It Means For Pharma Giants</a></li>
<li><a href="https://www.benzinga.com/general/health-care/25/01/43107039/elizabeth-warren-questions-robert-f-kennedy-jr-on-dangerous-views-pot-legalization-timeline-as-his-senate-hearing-stalls">Elizabeth Warren Questions Robert F. Kennedy Jr. On &#8216;Dangerous Views,&#8217; Pot Legalization Timeline As His Senate Hearing Stalls</a></li>
</ul>

GTBIF

ISPR

The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And More

Derek Maltz has been appointed acting administrator of the U.S. Drug Enforcement Administration, which places him at the helm of the agency amid <a href="https://www.benzinga.com/government/regulations/25/01/42882766/dea-accused-of-bias-in-cannabis-rescheduling-hearings-weed-stocks-plummeted-in-2024-as-process-drags-on?adt_ei={{email}}&amp;he={{email}}&amp;el=CannabisDaily">contentious debates</a> over cannabis rescheduling and President Donald Trump&#8217;s executive order designating drug cartels as foreign terrorists.
A 28-year DEA veteran, Maltz formerly led the New York Drug Enforcement Task Force, the nation's largest and oldest drug task force. The DEA <a href="https://www.dea.gov/press-releases/2025/01/21/career-special-agent-derek-s-maltz-appointed-lead-us-drug-enforcement">praised Maltz</a> as a staunch advocate in the fight against global drug trafficking and terrorism.
Maltz responded. "DEA is positioned to lead the nation's drug enforcement and intelligence efforts, working closely within the federal, state and local partners, to seize record amounts of illicit drugs; bring the world's most ruthless narco-terrorists to justice; and save American lives by creating a vast network of community partners to help spread critical awareness," Maltz <a href="https://www.dea.gov/press-releases/2025/01/21/career-special-agent-derek-s-maltz-appointed-lead-us-drug-enforcement">said</a> in a DEA press release.&nbsp;
<h1 class="wp-block-heading">Cannabis Rescheduling Process Is A Hot Mess</h1>
Maltz&#8217;s appointment comes as the agency faces scrutiny over its role in a Department of Justice <a href="https://www.benzinga.com/markets/cannabis/24/04/38530190/breaking-dea-reportedly-moves-to-reschedule-cannabis-stocks-rise-sharply-on-the-news">proposal to reschedule cannabis</a> from a Schedule I to a Schedule III drug under the Controlled Substances Act. The process came to a screeching halt in mid-January 2025 when a DEA judge <a href="https://www.benzinga.com/25/01/42972524/dea-judge-cancels-marijuana-rescheduling-hearing-amid-disturbing-allegations-of-improper-conduct">put the process on hold</a> for at least citing serious allegations of misconduct within the DEA.
The new DEA chief has been outspoken in his opposition to cannabis legalization, once tweeting that &#8220;all irresponsible politicians trying to get votes by legalizing marijuana&#8221; should understand the &#8220;negative impacts of smoking this crap.&#8221; Though the Associated Press <a href="https://apnews.com/article/marijuana-pot-dea-legalization-biden-cb7869d3286094f0124de728320d89c1">quoted him in 2024</a> saying, &#8220;If there&#8217;s scientific evidence to support cannabis rescheduling, then so be it. But you&#8217;ve got to let the scientists evaluate it.&#8221;
<h1 class="wp-block-heading">War On Mexican Drug Cartels</h1>
Maltz has long been a vocal proponent of designating Mexican drug cartels as foreign terrorist organizations, especially Mexico's <a href="https://www.benzinga.com/markets/cannabis/23/01/30614753/the-man-who-played-the-dea-el-chapos-sinaloa-cartel-us-government-on-trial-in-brooklyn">Sinaloa </a>and Jalisco cartels. &nbsp;
Hours after his inauguration, Trump did just that via <a href="https://www.whitehouse.gov/presidential-actions/2025/01/designating-cartels-and-other-organizations-as-foreign-terrorist-organizations-and-specially-designated-global-terrorists/">executive order</a>.
"The Cartels have engaged in a campaign of violence and terror throughout the Western Hemisphere that has not only destabilized countries with significant importance for our national interests but also flooded the United States with deadly drugs, violent criminals, and vicious gangs," Trump stated in the order.
Maltz sounded ready to undertake his marching orders. 
&#8220;DEA will continue to be relentless in our pursuit of the cartels who threaten this great nation," he <a href="https://www.dea.gov/press-releases/2025/01/21/career-special-agent-derek-s-maltz-appointed-lead-us-drug-enforcement">said</a>.&nbsp;
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/01/43149460/trumps-cannabis-reform-mike-tyson-weldon-angelos-say-president-can-get-it-done">Trump&#8217;s Cannabis Reform: Mike Tyson, Weldon Angelos Say President Can Get It Done</a></li>
</ul>
Photo: Courtesy of DEA

Global

Trump Appoints DEA Chief Who Will Bring 'Ruthless Narco-Terrorists To Justice,' Not Keen On Legalizing Cannabis

Press Releases

Easterly Government Properties Amends 2016 Senior Unsecured Term Loan Agreement

Easterly Government Properties Announces Tax Characteristics of Its 2024 Distributions

Easterly Government Properties Schedules Fourth Quarter 2024 Earnings Release and Conference Call

Easterly Government Properties CEO Advocates for GSA Reform Through DOGE Partnership

Easterly Government Properties Announces Quarterly Dividend

Easterly Government Properties Reports Fourth Quarter 2024 Results

Easterly Government Properties to Participate in the Citi 2025 Global Property CEO Conference

Easterly Government Properties Issues $125 Million in Senior Unsecured Notes

Easterly Government Properties Announces Reduction of Quarterly Dividend, Reverse Stock Split to Enhance Long-Term Growth Strategy and Reaffirms 2025 Guidance

Easterly Government Properties Schedules First Quarter 2025 Earnings Release and Conference Call

Comments

Easterly Government Props

Easterly Government Props (DEA) オプション

Easterly Government Props (NYSE:DEA) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル